The expression levels of SNAI3-AS1 were confirmed by qRT–PCR in normal human astrocytes and two glioma cell lines, as well as in tumors and adjacent normal tissues from 24 glioma patients (Supplementary Table S4). This evidence concerns the gene SNAI3 and central nervous system cancer.